In this study, we prepared several shortened and full-length insulin analogues with substitutions at position B26. We compared the binding affinities of the analogues for rat adipose membranes with their ability to lower the plasma glucose level in nondiabetic Wistar rats in vivo after subcutaneous administration, and also with their ability to stimulate lipogenesis in vitro. We found that [NMeHisB26]-DTI-NH 2 and [NMeAlaB26]-DTI-NH 2 were very potent insulin analogues with respect to their binding affinities (214 and 465%, respectively, compared to that of human insulin), but they were significantly less potent than human insulin in vivo. Their full-length counterparts, [NMeHisB26]-insulin and [NMeAlaB26]-insulin, were less effective than human insulin with respect to binding affinity (10 and 21%, respectively) and in vivo activity, while [HisB26]-insulin exhibited properties similar to those of human insulin in all of the tests we carried out. The ability of selected analogues to stimulate lipogenesis in adipocytes was correlated with their biological potency in vivo. Taken together, our data suggest that the B26 residue and residues B26-B30 have ambiguous roles in binding affinity and in vivo activity. We hypothesize that our shortened analogues, [NMeHisB26]-DTI-NH 2 and [NMeAlaB26]-DTI-NH 2, have different modes of interaction with the insulin receptor compared with natural insulin and that these different modes of interaction result in a less effective metabolic response of the insulin receptor, despite the high binding potency of these analogues.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Flemingovo nám 2 166 10 Praha 6 Czech Republic

Citace poskytuje Crossref.org

A radioligand binding assay for the insulin-like growth factor 2 receptor

A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding

Rational steering of insulin binding specificity by intra-chain chemical crosslinking

Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young

Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex

Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin

Structural integrity of the B24 site in human insulin is important for hormone functionality

Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface

Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues